Rod Woolliss, 28, was previously jailed for 10 years for attempted murder after he fired an eight-inch-long crossbow bolt into his victim’s cheek during a fight in Grimsby, North East Lincolnshire.

People in Norwich have spotted the person wearing a long black cloak, hat and pointed beak-like mask. Norfolk Police are keen to identify him to ‘provide him some words of advice’

Pensioners Paul and Wendy Cary, from Hampshire, are thousands of pounds out of pocket after their British Airways holiday to Barbados was hit by the travel ban.

Norwegian property tycoon Tom Hagen, 70, ‘forcefully maintains that he had nothing to do with’ the disappearance of his wife Anne-Elisabeth Hagen in 2018, his lawyer said.

The urge for states to reopen is understandable. Lockdown can’t continue forever, and the economy matters too. Low case counts make it look like the worst is over. But reopening now could still prove to be premature.

Warren Buffett, chairman and CEO of Berkshire Hathaway, has been a consistent voice of optimism on the U.S. economy and American innovation.

The Bureau of Economic Analysis released the advance print of U.S. first-quarter gross domestic product Wednesday morning.

The possibility of a breakout, and the chance to reap rewards, may be closer than we think. Writing from JPMorgan, quant analyst Marko Kolanovic sees the main chance turning toward a 2H20 economic recovery and new market records by 1H21. He bases his stance on new data showing that the COVID-19 pandemic may have already […]

Gilead Sciences Inc jumped 9.3% in premarket trading after the drugmaker said its experimental antiviral drug remdesivir helped improve symptoms for COVID-19 patients who were given the drug early. “The news on Gilead is really powering the market,” said Linda Duessel, senior equity strategist at Federated Hermes in Pittsburgh, Pennsylvania. Alphabet Inc jumped 8.7% as […]

Gilead Sciences (GILD) has reported that it is aware of positive data emerging from the critical National Institute of Allergy and Infectious Diseases’ (NIAID) study of remdesivir for the treatment of COVID-19.“We understand that the trial has met its primary endpoint and that NIAID will provide detailed information at an upcoming briefing” the company said […]